{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:09:50Z","timestamp":1761901790636,"version":"build-2065373602"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"FAPERGS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K07508"],"award-info":[{"award-number":["18K07508"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001697","name":"Keio University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001697","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["KAKENHI 15K19472"],"award-info":[{"award-number":["KAKENHI 15K19472"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.msard.2021.103407","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T02:04:34Z","timestamp":1637028274000},"page":"103407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Mechanisms of myelin repair, MRI techniques and therapeutic opportunities in multiple sclerosis"],"prefix":"10.1016","volume":"58","author":[{"given":"Rafael Canani","family":"Sommer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Hata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina de Medeiros","family":"Rimkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna","family":"Klein da Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas Kazutoshi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.msard.2021.103407_bib0081","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1093\/brain\/awm110","article-title":"In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study","volume":"130","author":"Agosta","year":"2007","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.msard.2021.103407_bib0018","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.yexmp.2017.11.004","article-title":"Remyelination modulators in multiple sclerosis patients","volume":"103","author":"Al-Temaimi","year":"2017","journal-title":"Exp. Mol. Pathol."},{"issue":"1","key":"10.1016\/j.msard.2021.103407_bib0052","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mrm.25198","article-title":"MRI-based myelin water imaging: a technical review","volume":"73","author":"Alonso-Ortiz","year":"2015","journal-title":"Magn. Reson. Med."},{"issue":"4","key":"10.1016\/j.msard.2021.103407_bib0029","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/hbm.23481","article-title":"Test\u2013retest reliability and concurrent validity of in vivo myelin content indices: myelin water fraction and calibrated T1w\/T2w image ratio","volume":"38","author":"Arshad","year":"2017","journal-title":"Hum. Brain Mapp."},{"issue":"5","key":"10.1016\/j.msard.2021.103407_bib0059","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/1522-2594(200011)44:5<713::AID-MRM9>3.0.CO;2-6","article-title":"Displacement imaging of spinal cord using q-space diffusion-weighted MRI","volume":"44","author":"Assaf","year":"2000","journal-title":"Magn. Reson. Med."},{"issue":"5","key":"10.1016\/j.msard.2021.103407_bib0042","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/jmri.20178","article-title":"Voxel-based analysis of MTR images: a method to locate gray matter abnormalities in patients at the earliest stage of multiple sclerosis","volume":"20","author":"Audoin","year":"2004","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.msard.2021.103407_bib0006","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fnmol.2019.00225","article-title":"Central nervous system remyelination: roles of glia and innate immune cells","volume":"12","author":"Baaklini","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"8","key":"10.1016\/j.msard.2021.103407_bib0026","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/brain\/awg182","article-title":"Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years","volume":"126","author":"Bagnato","year":"2003","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.msard.2021.103407_bib0024","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archneur.60.8.1073","article-title":"Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance","volume":"60","author":"Barkhof","year":"2003","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2021.103407_bib0025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/135245859900500415","article-title":"MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS)","volume":"5","author":"Barkhof","year":"1999","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.msard.2021.103407_bib0058","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.mri.2005.10.029","article-title":"High b-value q-space diffusion MRI in myelin-deficient rat spinal cords","volume":"24","author":"Biton","year":"2006","journal-title":"Magn. Reson. Imaging"},{"issue":"6","key":"10.1016\/j.msard.2021.103407_bib0012","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00401-013-1112-y","article-title":"Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models","volume":"125","author":"Boyd","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.msard.2021.103407_bib0015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.nicl.2014.06.009","article-title":"Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis","volume":"6","author":"Brown","year":"2014","journal-title":"NeuroImage Clin."},{"issue":"9","key":"10.1016\/j.msard.2021.103407_bib0096","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S1474-4422(21)00179-4","article-title":"Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study","volume":"20","author":"Brown","year":"2021","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.msard.2021.103407_bib0085","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1474-4422(16)30377-5","article-title":"Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial","volume":"16","author":"Cadavid","year":"2017","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.msard.2021.103407_bib0086","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S1474-4422(19)30137-1","article-title":"Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial","volume":"18","author":"Cadavid","year":"2019","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.msard.2021.103407_bib0073","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/jon.12553","article-title":"Spinal cord atrophy in multiple sclerosis: a systematic review and meta-analysis","volume":"28","author":"Casserly","year":"2018","journal-title":"J. Neuroimaging"},{"issue":"2","key":"10.1016\/j.msard.2021.103407_bib0038","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ana.21302","article-title":"Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions","volume":"63","author":"Chen","year":"2008","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.msard.2021.103407_bib0094","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0189380","article-title":"Histamine receptor 3 negatively regulates oligodendrocyte differentiation and remyelination","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.msard.2021.103407_bib0093","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S1474-4422(20)30347-1","article-title":"Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"19","author":"Cree","year":"2020","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.msard.2021.103407_bib0022","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00415-019-09421-x","article-title":"Promoting remyelination in multiple sclerosis","volume":"268","author":"Cunniffe","year":"2021","journal-title":"J. Neurol."},{"issue":"13","key":"10.1016\/j.msard.2021.103407_bib0041","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.0b013e318212a8be","article-title":"MRI predictors of cognitive outcome in early multiple sclerosis","volume":"76","author":"Deloire","year":"2011","journal-title":"Neurology"},{"issue":"50","key":"10.1016\/j.msard.2021.103407_bib0008","doi-asserted-by":"crossref","first-page":"E11807","DOI":"10.1073\/pnas.1808064115","article-title":"The adult oligodendrocyte can participate in remyelination","volume":"115","author":"Duncan","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.msard.2021.103407_bib0074","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/brain\/awy088","article-title":"Progression of regional grey matter atrophy in multiple sclerosis","volume":"141","author":"Eshaghi","year":"2018","journal-title":"Brain"},{"issue":"16 Supplement","key":"10.1016\/j.msard.2021.103407_bib0090","doi-asserted-by":"crossref","first-page":"P2.100","DOI":"10.1212\/WNL.88.16_supplement.P2.100","article-title":"Exploratory MRI biomarkers of opicinumab (Anti-LINGO-1) show stabilization of pre-existing T2 lesions in relapsing multiple sclerosis: results from the phase 2b SYNERGY trial (P2.100)","volume":"88","author":"Evans","year":"2017","journal-title":"Neurology"},{"issue":"7399","key":"10.1016\/j.msard.2021.103407_bib0003","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature11007","article-title":"Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity","volume":"485","author":"F\u00fcnfschilling","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.msard.2021.103407_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0151496","article-title":"Heterogeneity of multiple sclerosis lesions in multislice myelin water imaging","volume":"11","author":"Faizy","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.msard.2021.103407_bib0066","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/nbm.3140","article-title":"Histological correlation of diffusional kurtosis and white matter modeling metrics in cuprizone-induced corpus callosum demyelination","volume":"27","author":"Falangola","year":"2014","journal-title":"NMR Biomed."},{"issue":"5","key":"10.1016\/j.msard.2021.103407_bib0060","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/mrm.21563","article-title":"High b-value q-space diffusion-weighted MRI of the human cervical spinal cord in vivo: feasibility and application to multiple sclerosis","volume":"59","author":"Farrell","year":"2008","journal-title":"Magn. Reson. Med."},{"issue":"1","key":"10.1016\/j.msard.2021.103407_bib0055","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3174\/ajnr.A2238","article-title":"Measuring myelin repair and axonal loss with diffusion tensor imaging","volume":"32","author":"Fox","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"issue":"11","key":"10.1016\/j.msard.2021.103407_bib0004","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrn2480","article-title":"Remyelination in the CNS: from biology to therapy","volume":"9","author":"Franklin","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"12","key":"10.1016\/j.msard.2021.103407_bib0007","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrn.2017.136","article-title":"Regenerating CNS myelin-from mechanisms to experimental medicines","volume":"18","author":"Franklin","year":"2017","journal-title":"Nat Rev Neurosci"},{"issue":"9","key":"10.1016\/j.msard.2021.103407_bib0056","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1523\/JNEUROSCI.1770-15.2016","article-title":"Application of q-space diffusion MRI for the visualization of white matter","volume":"36","author":"Fujiyoshi","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.msard.2021.103407_bib0030","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3389\/fnhum.2014.00671","article-title":"Whole brain myelin mapping using T1- and T2-weighted MR imaging data","volume":"8","author":"Ganzetti","year":"2014","journal-title":"Front. Hum. Neurosci."},{"issue":"2","key":"10.1016\/j.msard.2021.103407_bib0011","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s10495-018-1448-9","article-title":"Dynamic changes and molecular analysis of cell death in the spinal cord of SJL mice infected with the BeAn strain of Theiler\u2019s murine encephalomyelitis virus","volume":"23","author":"Gerhauser","year":"2018","journal-title":"Apoptosis"},{"issue":"22","key":"10.1016\/j.msard.2021.103407_bib0017","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181a8260a","article-title":"Remyelination capacity of the MS brain decreases with disease chronicity","volume":"72","author":"Goldschmidt","year":"2009","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.msard.2021.103407_bib0032","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1093\/brain\/awx247","article-title":"In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis","volume":"140","author":"Granberg","year":"2017","journal-title":"Brain"},{"doi-asserted-by":"crossref","unstructured":"Green, A.J., Gelfand, J.M., Cree, B.A., Bevan, C., Boscardin, W.J., Mei, F., et\u00a0al. 2017 Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. Lancet. 2017 2;390(10111):2481-2489. doi: 10.1016\/S0140-6736(17)32346-2.","key":"10.1016\/j.msard.2021.103407_bib0051","DOI":"10.1016\/S0140-6736(17)32346-2"},{"issue":"2","key":"10.1016\/j.msard.2021.103407_bib0033","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1148\/radiographics.14.2.8190954","article-title":"Magnetization transfer: theory and clinical applications in neuroradiology","volume":"14","author":"Grossman","year":"1994","journal-title":"RadioGraphics"},{"issue":"8","key":"10.1016\/j.msard.2021.103407_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells8080825","article-title":"The molecular basis for remyelination failure in multiple sclerosis","volume":"8","author":"Gruchot","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.msard.2021.103407_bib0067","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.neuroimage.2015.10.052","article-title":"Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelination","volume":"125","author":"Guglielmetti","year":"2016","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.msard.2021.103407_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-28852-6","article-title":"Myelin measurement: comparison between simultaneous tissue relaxometry, magnetization transfer saturation index, and T1w\/T2w ratio methods","volume":"8","author":"Hagiwara","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.msard.2021.103407_bib0043","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/brain\/awh076","article-title":"Serial magnetization transfer imaging in acute optic neuritis","volume":"127","author":"Hickman","year":"2004","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.msard.2021.103407_bib0077","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.mri.2004.01.056","article-title":"Cervical spinal cord MTR histogram analysis in multiple sclerosis using a 3D acquisition and a B-spline active surface segmentation technique","volume":"22","author":"Hickman","year":"2004","journal-title":"Magn. Reson. Imaging"},{"issue":"4","key":"10.1016\/j.msard.2021.103407_bib0057","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2463\/mrms.11.221","article-title":"Visualizing non-gaussian diffusion: clinical application of q-space imaging and diffusional kurtosis imaging of the brain and spine","volume":"11","author":"Hori","year":"2012","journal-title":"Magn. Reson. Med. Sci."},{"issue":"4","key":"10.1016\/j.msard.2021.103407_bib0062","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2463\/mrms.11.221","article-title":"Visualizing non-gaussian diffusion: clinical application of q-space imaging and diffusional kurtosis imaging of the brain and spine","volume":"11","author":"Hori","year":"2012","journal-title":"Magn. Reson. Med. Sci."},{"issue":"6","key":"10.1016\/j.msard.2021.103407_bib0061","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.mri.2014.02.024","article-title":"Multiple sclerosis: benefits of q-space imaging in evaluation of normal-appearing and periplaque white matter","volume":"32","author":"Hori","year":"2014","journal-title":"Magn. Reson. Imaging"},{"issue":"Pt 1","key":"10.1016\/j.msard.2021.103407_bib0098","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/brain\/aws284","article-title":"The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination","volume":"136","author":"Hussain","year":"2013","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.msard.2021.103407_bib0035","doi-asserted-by":"crossref","first-page":"853LP","DOI":"10.1212\/01.WNL.0000049929.27032.29","article-title":"The effect of interferon \u03b2-1b on quantities derived from MT MRI in secondary progressive MS","volume":"60","author":"Inglese","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2021.103407_bib0044","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neuroimage.2016.02.004","article-title":"In vivo quantification of demyelination and recovery using compartment-specific diffusion MRI metrics validated by electron microscopy","volume":"132","author":"Jelescu","year":"2016","journal-title":"Neuroimage"},{"issue":"6","key":"10.1016\/j.msard.2021.103407_bib0065","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/mrm.20508","article-title":"Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging","volume":"53","author":"Jensen","year":"2005","journal-title":"Magn. Reson. Med."},{"issue":"6","key":"10.1016\/j.msard.2021.103407_bib0072","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrneurol.2015.80","article-title":"Spinal cord MRI in multiple sclerosis\u2013diagnostic, prognostic and clinical value","volume":"11","author":"Kearney","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2021.103407_bib0040","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1001\/archneur.65.11.1454","article-title":"Magnetization transfer ratio in gray matter: a potential surrogate marker for progression in early primary progressive multiple sclerosis","volume":"65","author":"Khaleeli","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2021.103407_bib0071","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jns.2017.01.008","article-title":"Q-space myelin map imaging: a new imaging technique for treatment evaluation in multiple sclerosis","volume":"373","author":"Kira","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.msard.2021.103407_bib0076","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.neuroimage.2011.01.007","article-title":"Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords","volume":"55","author":"Klawiter","year":"2011","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.msard.2021.103407_bib0021","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1523\/JNEUROSCI.2615-05.2006","article-title":"Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation","volume":"26","author":"Kotter","year":"2006","journal-title":"J. Neurosci."},{"doi-asserted-by":"crossref","unstructured":"K. Kufukihara, M. Tanikawa, J. Hata, S. Suzuki, K. Fujiyoshi, H. Fujiwara, M. Jinzaki, M. Nakamura, H. Okano, S. Takahashi, J. Nakahara. Q-space myelin map imaging for longitudinal analysis of remyelination in multiple sclerosis patients treated with natalizumab. ECTRIMS Online Library. 2018; Available from: https:\/\/onlinelibrary.ectrims-congress.eu\/ectrims\/2018\/ectrims-2018\/228671\/kenji.kufukihara.q-space.myelin.map.imaging.for.longitudinal.analysis.of.html.","key":"10.1016\/j.msard.2021.103407_bib0070","DOI":"10.26226\/morressier.5b7578645aff7400151f3832"},{"issue":"7","key":"10.1016\/j.msard.2021.103407_bib0014","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/brain\/awn096","article-title":"Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis","volume":"131","author":"Kuhlmann","year":"2008","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.msard.2021.103407_bib0063","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mri.2007.04.001","article-title":"In vivo visualization of displacement-distribution-derived parameters in q-space imaging","volume":"26","author":"L\u00e4tt","year":"2008","journal-title":"Magn. Reson. Imaging"},{"issue":"6","key":"10.1016\/j.msard.2021.103407_bib0047","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1177\/1352458506070928","article-title":"Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology","volume":"12","author":"Laule","year":"2006","journal-title":"Mult. Scler. J."},{"issue":"4","key":"10.1016\/j.msard.2021.103407_bib0048","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.neuroimage.2007.12.008","article-title":"Myelin water imaging of multiple sclerosis at 7 T: correlations with histopathology","volume":"40","author":"Laule","year":"2008","journal-title":"Neuroimage"},{"issue":"11","key":"10.1016\/j.msard.2021.103407_bib0075","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1177\/1352458515624559","article-title":"High-resolution myelin water imaging in post-mortem multiple sclerosis spinal cord: a case report","volume":"22","author":"Laule","year":"2016","journal-title":"Mult. Scler."},{"issue":"7408","key":"10.1016\/j.msard.2021.103407_bib0002","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature11314","article-title":"Oligodendroglia metabolically support axons and contribute to neurodegeneration","volume":"487","author":"Lee","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.msard.2021.103407_bib0068","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12883-018-1108-2","article-title":"Evaluation of patients with relapsing-remitting multiple sclerosis using tract-based spatial statistics analysis: diffusion kurtosis imaging","volume":"18","author":"Li","year":"2018","journal-title":"BMC Neurol."},{"issue":"8","key":"10.1016\/j.msard.2021.103407_bib0005","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1474-4422(20)30140-X","article-title":"Remyelination in multiple sclerosis: from basic science to clinical translation","volume":"19","author":"Lubetzki","year":"2020","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.msard.2021.103407_bib0078","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/jnnp-2014-307650","article-title":"Imaging outcomes for trials of remyelination in multiple sclerosis","volume":"85","author":"Mallik","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.msard.2021.103407_bib0045","first-page":"1173","volume":"45","author":"Mccreary","year":"2010","journal-title":"NIH Public Access"},{"issue":"16 Supplement","key":"10.1016\/j.msard.2021.103407_bib0088","doi-asserted-by":"crossref","first-page":"P5.369","DOI":"10.1212\/WNL.88.16_supplement.P5.369","article-title":"Safety and tolerability of opicinumab in relapsing multiple sclerosis: the phase 2b SYNERGY trial (P5.369)","volume":"88","author":"McCroskery","year":"2017","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.msard.2021.103407_bib0091","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nm.3618","article-title":"Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis","volume":"20","author":"Mei","year":"2014","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.msard.2021.103407_bib0083","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.21581","article-title":"Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells","volume":"65","author":"Mi","year":"2009","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2021.103407_bib0019","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41467-017-02719-2","article-title":"Pharmacogenetic stimulation of neuronal activity increases myelination in an axon-specific manner","volume":"9","author":"Mitew","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.msard.2021.103407_bib0001","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa1606468","article-title":"Ocrelizumab versus placebo in primary progressive multiple sclerosis","volume":"376","author":"Montalban","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.msard.2021.103407_bib0036","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00415-003-0192-3","article-title":"High field MRI correlates of myelin content and axonal density in multiple sclerosis: a post-mortem study of the spinal cord","volume":"250","author":"Mottershead","year":"2003","journal-title":"J. Neurol."},{"issue":"24","key":"10.1016\/j.msard.2021.103407_bib0080","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1212\/WNL.0b013e318296e8f1","article-title":"Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease","volume":"80","author":"Naismith","year":"2013","journal-title":"Neurology"},{"doi-asserted-by":"crossref","unstructured":"Nakahara, J. Visualization of myelin for the diagnosis and treatment monitoring of multiple sclerosis BT - myelin: basic and clinical advances. In: Sango K., Yamauchi J., Ogata T., Susuki K., eds. Singapore: Springer Singapore; 2019. p. 249\u201356. Available from: 10.1007\/978-981-32-9636-7_15.","key":"10.1016\/j.msard.2021.103407_bib0053","DOI":"10.1007\/978-981-32-9636-7_15"},{"issue":"12","key":"10.1016\/j.msard.2021.103407_bib0016","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/brain\/awl217","article-title":"Remyelination is extensive in a subset of multiple sclerosis patients","volume":"129","author":"Patrikios","year":"2006","journal-title":"Brain"},{"issue":"15 Supplement","key":"10.1016\/j.msard.2021.103407_bib0089","doi-asserted-by":"crossref","first-page":"P6.345","DOI":"10.1212\/WNL.90.15_supplement.P6.345","article-title":"Effects of opicinumab on patient-reported outcomes in participants with relapsing multiple sclerosis: a post-hoc analysis of the phase 2 SYNERGY study (P6.345)","volume":"90","author":"Petrillo","year":"2018","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2021.103407_bib0010","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrd.2017.115","article-title":"Remyelination therapies: a new direction and challenge in multiple sclerosis","volume":"16","author":"Plemel","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.msard.2021.103407_bib0082","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3174\/ajnr.A3512","article-title":"A better characterization of spinal cord damage in multiple sclerosis: a diffusional kurtosis imaging study","volume":"34","author":"Raz","year":"2013","journal-title":"Am. J. Neuroradiol."},{"issue":"4","key":"10.1016\/j.msard.2021.103407_bib0031","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ana.25020","article-title":"Cortical pathology in multiple sclerosis detected by the T1\/T2-weighted ratio from routine magnetic resonance imaging","volume":"82","author":"Righart","year":"2017","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2021.103407_bib0097","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-58709-w","article-title":"Nanocatalytic activity of clean-surfaced, faceted nanocrystalline gold enhances remyelination in animal models of multiple sclerosis","volume":"10","author":"Robinson","year":"2020","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.msard.2021.103407_bib0087","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/14737175.2017.1378098","article-title":"Anti lingo 1 (opicinumab) a new monoclonal antibody tested in relapsing remitting multiple sclerosis","volume":"17","author":"Ruggieri","year":"2017","journal-title":"Expert. Rev. Neurother."},{"issue":"3","key":"10.1016\/j.msard.2021.103407_bib0037","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ana.20202","article-title":"Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain","volume":"56","author":"Schmierer","year":"2004","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2021.103407_bib0095","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00415-016-8341-7","article-title":"Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study","volume":"264","author":"Schwartzbach","year":"2017","journal-title":"J. Neurol."},{"issue":"8","key":"10.1016\/j.msard.2021.103407_bib0009","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/13543784.2021.1942840","article-title":"Remyelination therapies for multiple sclerosis: optimizing translation from animal models into clinical trials","volume":"30","author":"Sutiwisesak","year":"2021","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.msard.2021.103407_bib0069","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jns.2017.01.009","article-title":"Q-space myelin map imaging for longitudinal analysis of demyelination and remyelination in multiple sclerosis patients treated with fingolimod: a preliminary study","volume":"373","author":"Tanikawa","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.msard.2021.103407_bib0027","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3174\/ajnr.A5004","article-title":"T1 recovery is predominantly found in black holes and is associated with clinical improvement in patients with multiple sclerosis","volume":"38","author":"Thaler","year":"2017","journal-title":"Am. J. Neuroradiol."},{"issue":"13","key":"10.1016\/j.msard.2021.103407_bib0092","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1177\/1352458516667568","article-title":"MS-SPI study group, 2016. MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study","volume":"22","author":"Tourbah","year":"2016","journal-title":"Mult Scler"},{"issue":"6","key":"10.1016\/j.msard.2021.103407_bib0039","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1191\/1352458503ms958oa","article-title":"Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities","volume":"9","author":"Traboulsee","year":"2003","journal-title":"Mult. Scler. J."},{"issue":"2","key":"10.1016\/j.msard.2021.103407_bib0084","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1212\/NXI.0000000000000018","article-title":"Randomized phase I trials of the safety\/tolerability of anti-LINGO-1 monoclonal antibody BIIB033","volume":"1","author":"Tran","year":"2014","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.msard.2021.103407_bib0064","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/RMR.0b013e31823e6303","article-title":"An introduction to model-independent diffusion magnetic resonance imaging","volume":"21","author":"Van","year":"2010","journal-title":"Top. Magn. Reson. Imaging"},{"key":"10.1016\/j.msard.2021.103407_bib0049","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.nicl.2015.09.003","article-title":"Measuring longitudinal myelin water fraction in new multiple sclerosis lesions","volume":"9","author":"Vargas","year":"2015","journal-title":"NeuroImage Clin."},{"issue":"10","key":"10.1016\/j.msard.2021.103407_bib0046","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrneurol.2015.157","article-title":"MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients","volume":"11","author":"Wattjes","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2021.103407_bib0034","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/mrm.1910100113","article-title":"Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo","volume":"10","author":"Wolff","year":"1989","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.msard.2021.103407_bib0054","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuint.2017.10.004","article-title":"Neurochemistry international quantitative temporal changes in DTI values coupled with histological properties in cuprizone-induced demyelination and remyelination","volume":"119","author":"Yano","year":"2018","journal-title":"Neurochem. Int."},{"issue":"7745","key":"10.1016\/j.msard.2021.103407_bib0013","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41586-018-0842-3","article-title":"Dynamics of oligodendrocyte generation in multiple sclerosis","volume":"566","author":"Yeung","year":"2019","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.msard.2021.103407_bib0079","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/brain\/awp032","article-title":"Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cord","volume":"132","author":"Zackowski","year":"2009","journal-title":"Brain"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482100674X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482100674X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:57:33Z","timestamp":1761901053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482100674X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":97,"alternative-id":["S221103482100674X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.103407","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of myelin repair, MRI techniques and therapeutic opportunities in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.103407","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103407"}}